To The Moon

🐯 Hi Tigers, here's the setup:

Wall Street analysts reshuffled their views across technology, industrials, energy, utilities, healthcare and consumer stocks last week.

From bullish calls on agricultural equipment and AI infrastructure to sharp target cuts in healthcare and utilities, the week's rating changes offered a glimpse into where analysts are becoming more confident — and where expectations are being reset.

Here’s a day-by-day look at some of the most notable rating upgrades and downgrades from Aug. 31 through Sept. 4.

📅 Day 1 — Agricultural Recovery Meets Utility Caution

The week opened with analysts becoming more constructive on agricultural equipment while taking a more cautious stance on several utilities.

$Deere(DE)$ received an upgrade from Baird to Outperform from Neutral, with its price target raised from $640 to $800. Baird pointed to Deere's strong exposure to North American row-crop equipment demand and what it sees as a cleaner setup for an agricultural recovery.

$AGCO Corp(AGCO)$ was also upgraded by Baird to Outperform from Neutral, with its target raised from $120 to $150. The simultaneous upgrades suggest Baird sees improving agricultural fundamentals as a potential catalyst across the farm-equipment sector.

On the other side, $Edison(EIX)$ and $Sempra(SRE)$ faced more cautious views, with analysts cutting their ratings and price targets amid concerns surrounding the utilities' outlook and risk profile.

Trader takeaway:
Monday's calls showed Wall Street looking beyond the AI trade for cyclical recovery opportunities, while utility stocks faced a more difficult valuation and risk assessment.

📅 Day 2 — Digital Platforms Gain Conviction

The second day shifted attention toward digital platforms, cybersecurity and financial technology, while utilities continued to face pressure.

$Akamai(AKAM)$ was upgraded by Piper Sandler to Overweight from Neutral with a $125 target, reflecting stronger confidence in its cloud, cybersecurity and edge-computing businesses.

$Duolingo, Inc.(DUOL)$ received an upgrade from Evercore ISI to Outperform from In Line, with its target price doubled from $105 to $210. The move reflects increased confidence in user growth, monetization and the company's digital education platform.

$Robinhood(HOOD)$ was raised by Morgan Stanley to Overweight from Equal Weight, with its target lifted from $124 to $150. Analysts pointed to Robinhood's expanding product ecosystem and growing revenue opportunities beyond traditional stock and crypto trading.

Meanwhile, $Edison(EIX)$ was downgraded by Bank of America to Neutral from Buy, with its target cut sharply from $81 to $51. $PG&E Corp(PCG)$ was similarly reduced to Neutral, with its target falling from $24 to $13.

Trader takeaway:
Growth platforms continued to attract analyst conviction, but the sharp utility target cuts showed that sector-specific risks and valuation concerns remained significant.

📅 Day 3 — Infrastructure Optimism Meets Healthcare & EV Caution

Wednesday brought a more mixed picture, with analysts becoming more positive on selected infrastructure and travel names while cutting expectations for several healthcare and EV companies.

$InterContinental Hotels Group PLC(IHG)$ was upgraded by UBS to Buy from Neutral, with its target raised from $157.65 to $188. The move reflected a more constructive view of the hotel group's earnings outlook.

$Martin Marietta Materials(MLM)$ was upgraded by JPMorgan to Overweight from Neutral, although its $680 target remained unchanged. The move suggests JPMorgan's conviction improved without requiring a major change to its valuation assumptions.

On the downside, $EyePoint(EYPT)$ was downgraded by TD Cowen to Hold from Buy, with its price target slashed from $20 to $4. The 80% target reduction made it one of the week's most dramatic analyst resets.

$NIO Inc.(NIO)$ was also downgraded by JPMorgan to Neutral from Overweight, with its target cut from $7 to $4.45, reflecting a more cautious risk/reward assessment for the Chinese EV maker.

Trader takeaway:
The day's rating moves highlighted a growing divide between infrastructure and established businesses with improving outlooks and companies facing stronger execution, competitive or valuation concerns.

📅 Day 4 — AI Infrastructure Takes Center Stage

Thursday was arguably the week's biggest day for AI infrastructure upgrades, with analysts becoming more bullish on companies supplying the hardware behind the AI buildout.

$Broadcom(AVGO)$ was upgraded by Macquarie to Outperform from Neutral with a $490 target. The bullish case centers on Broadcom's exposure to custom AI accelerators and networking, areas benefiting from hyperscalers expanding their AI infrastructure.

$Dell Technologies Inc.(DELL)$ was upgraded by Fox Advisors to Outperform from Equal Weight with a $625 target. Dell's server and infrastructure businesses give it exposure to the growing amount of physical equipment required to support AI workloads.

$Deere(DE)$ received another upgrade, this time from Evercore ISI to Outperform from Market Perform with an $813 target. The second bullish call on Deere in the same week reinforced the improving analyst sentiment around the agricultural equipment cycle.

Meanwhile, $Moderna, Inc.(MRNA)$ was downgraded by Rothschild & Co Redburn to Sell from Hold with an $81 target, while $Ultragenyx Pharmaceutical(RARE)$ was cut by Evercore ISI to In Line from Outperform, with its target reduced from $34 to $16.

The Ultragenyx move was particularly notable because its shares also plunged after a key clinical-trial setback, prompting multiple analysts to reassess the stock.

Trader takeaway:
AI infrastructure remained one of Wall Street's strongest areas of conviction, but the healthcare downgrades showed that company-specific fundamentals can quickly outweigh broader sector optimism.

📅 Day 5 — Energy Gains Momentum as Analysts Reassess Tech

The final day brought a notable contrast between energy optimism and more cautious views on selected technology names.

$SHELL PLC SPON ADS EACH REPR 2 ORD SHS(SHEL)$ was upgraded by Morgan Stanley to Overweight from Equal Weight, with its price target raised from $81.60 to $101.30. The upgrade came as elevated oil prices and ongoing Middle East tensions supported a more constructive view of the energy sector.

$Ormat(ORA)$ was also upgraded by Bernstein to Market Perform from Underperform, although its $112 target remained unchanged.

On the downside, $Ambarella(AMBA)$ was downgraded by Craig-Hallum to Hold from Buy, with its target cut from $95 to $70. The move highlights how valuation and execution concerns can outweigh exposure to attractive themes such as AI-enabled edge computing.

An interesting case came from $Total SA(TTE)$. Morgan Stanley downgraded the stock to Equal Weight from Overweight but actually raised its price target from $88 to $90. That shows why a rating change should not be interpreted in isolation.

Trader takeaway:
Energy attracted stronger conviction as oil prices remained elevated, while Ambarella and TotalEnergies showed that ratings and price targets can move in different directions depending on an analyst's view of relative risk and reward.

🧩 What Last Week's Rating Moves Tell Us

Across the five trading days, several themes stood out.

1. AI Is Expanding Beyond GPUs

$Broadcom(AVGO)$ and $Dell Technologies Inc.(DELL)$ both received bullish upgrades, highlighting how Wall Street's AI thesis is spreading into custom chips, networking, servers and data-center infrastructure.

2. Cyclical Recovery Is Returning to the Conversation

$Deere(DE)$ and $AGCO Corp(AGCO)$ both received upgrades, suggesting analysts are beginning to see potential improvement in agricultural equipment demand after a weaker cycle.

3. Oil Is Supporting Energy Conviction

$SHELL PLC SPON ADS EACH REPR 2 ORD SHS(SHEL)$'s upgrade showed how elevated oil prices and geopolitical uncertainty can influence expectations for energy companies.

4. Valuation Still Matters

$Ambarella(AMBA)$'s downgrade is a reminder that exposure to AI or another popular growth theme doesn't automatically translate into a positive rating. Analysts also consider valuation, execution and how much future growth is already reflected in the share price.

5. A Downgrade Doesn't Always Mean a Lower Target

$Total SA(TTE)$ is a good example: Morgan Stanley reduced its rating but increased the price target.

The reason is that rating and target answer different questions.

The price target reflects an analyst's estimated value, while the rating also incorporates the stock's expected return relative to other opportunities and its risk/reward profile.

🐯 Tiger's Corner: Your Turn!

Which analyst move caught your attention most last week — the bullish AI infrastructure calls, the Deere upgrades, the energy boost for Shell, or the sharp healthcare downgrades?

Share your reasoning below. Thoughtful comments may receive Tiger Coins! 🪙

Analyst ratings and price targets reflect individual firms' views and are not guarantees of future performance. This article is for educational and informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security.